Cytomegalovirus Retinitis
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Retinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS [Phase 3]
This completed Phase 3 randomized trial evaluated intravenous ganciclovir for peripheral cytomegalovirus retinitis in patients with AIDS.
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [NA]
Clinical trial update for the SOCA study evaluating foscarnet-ganciclovir in CMV retinitis associated with AIDS; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: CMV Retinitis Retreatment Trial [Phase 2]
A Phase 2 retreatment trial investigating cytomegalovirus retinitis in HIV-infected individuals has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis [Phase 4]
Phase 4 trial comparing cidofovir and ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients has completed.
-
FDA approval · 2010-06-21FDA Approved: GANCICLOVIR — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for GANCICLOVIR SODIUM (ganciclovir), marking a generic approval.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Ganciclovir Implant Study for Cytomegalovirus Retinitis [Phase 3]
A Phase 3 study evaluating a ganciclovir implant for cytomegalovirus retinitis has completed.
-
FDA approval · 2009-09-15FDA Approved: ZIRGAN — Original Application (Bausch & Lomb Incorporated)
FDA approved Zirgan (ganciclovir ophthalmic gel) under its original application by Bausch & Lomb for the treatment of cytomegalovirus retini…
-
FDA approval · 2009-08-28FDA Approved: VALCYTE — Original Application (H2-Pharma, LLC)
FDA approved VALCYTE (valganciclovir hydrochloride) under the original application for cytomegalovirus infections, including CMV retinitis i…
-
FDA approval · 2009-02-26FDA Approved: GANCICLOVIR — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ganciclovir sodium (generic ganciclovir) submitted by Hikma Pharmaceuticals USA Inc., under ANDA…
-
CLINICAL_TRIALS trial_result · 2008-09-30Clinical Trial Update: A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis [Phase 3]
Phase 3 trial evaluating intravenous ganciclovir for immediately sight-threatening cytomegalovirus retinitis in AIDS patients has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-04Clinical Trial Update: A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection
This clinical trial compares HIV-infected patients with and without AIDS-related opportunistic infections, examining outcomes related to cyt…
-
CLINICAL_TRIALS trial_result · 2008-07-30Clinical Trial Update: A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy
A completed clinical trial assessing whether stopping maintenance therapy for Cytomegalovirus Retinitis is safe after effective anti-HIV the…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Efficacy of Elevated CD4 Counts on CMV Retinitis
This completed clinical trial evaluated whether elevated CD4 counts improve outcomes in cytomegalovirus retinitis among individuals with acq…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Immune Activity Against CVM Retinitis
A completed clinical trial evaluated immune activity against Cytomegalovirus retinitis in individuals with Acquired Immunodeficiency Syndrom…